Manual of Clinical Microbiology, Volume 2Patrick R. Murray, Ellen Jo Baron ASM Press, 2003 - 2113 pagine Since its inaugural edition was published in 1970, the Manual of Clinical Microbiology has been hailed as the gold standard for excellence among clinical microbiology books. That tradition of quality continues with the publication of the new eighth edition. Greatly expanded and reorganized into two volumes, MCM is the definitive resource for the microbiology, epidemiology, and clinical significance of all clinically important bacteria, viruses, fungi, and parasites. This invaluable text provides all microbiologists, laboratorians, and infectious disease professionals with the authoritative reference for running an effective, state-of-the-art diagnostic laboratory. No other single resource offers extensive, up-to-date information to address both the practical and esoteric questions. MCM sets the standard for reliability and day-to-day utility as a reference work for all busy professionals in the diagnostic laboratory and infectious disease communities. Guiding the clinical microbiologist in the selection, performance, and interpretation of laboratory procedures, MCM focuses on the when and why of diagnostic procedures, as well as the how. It presents a direct approach to organizing information with thorough but concise treatments of all the major areas of microbiology, including new microbial discoveries, changing diagnostic methods, and emerging therapeutic challenges facing clinicians. |
Dall'interno del libro
Risultati 1-3 di 98
Pagina 1329
... vaccine , p . 475–507 . In S. Plotkin and W. Orenstein ( ed . ) , Vaccines , 3rd ed . The W. B. Saunders Co. , Philadelphia , Pa . 18. Gershon , A. A. , S. Steinberg , L. Gelb , and NIAID Collaborative Varicella Vaccine Study Group ...
... vaccine , p . 475–507 . In S. Plotkin and W. Orenstein ( ed . ) , Vaccines , 3rd ed . The W. B. Saunders Co. , Philadelphia , Pa . 18. Gershon , A. A. , S. Steinberg , L. Gelb , and NIAID Collaborative Varicella Vaccine Study Group ...
Pagina 1379
... vaccine devel- oped in the 1960s demonstrated disease enhancement in vaccine recipients upon subsequent exposure to natural RSV ( 14 , 26 , 50 , 54 ) . Neither a parenteral live virus vac- cine nor live attenuated intranasal vaccines ...
... vaccine devel- oped in the 1960s demonstrated disease enhancement in vaccine recipients upon subsequent exposure to natural RSV ( 14 , 26 , 50 , 54 ) . Neither a parenteral live virus vac- cine nor live attenuated intranasal vaccines ...
Pagina 1395
... vaccinated , no history of measles Not vaccinated , no history of measles Previously vaccinated , primary vaccine failure Previously vaccinated , IgG positive Previously vaccinated , 1962 ( 65 , 99 ) . Introduction of rubella vaccine ...
... vaccinated , no history of measles Not vaccinated , no history of measles Previously vaccinated , primary vaccine failure Previously vaccinated , IgG positive Previously vaccinated , 1962 ( 65 , 99 ) . Introduction of rubella vaccine ...
Sommario
SECTION VIII | 1201 |
CHAPIN REAGENTS STAINS MEDIA | 1202 |
Phenotypic and Chryseobacterium Moraxella and Other | 1204 |
Copyright | |
67 sezioni non visualizzate
Parole e frasi comuni
acid activity acute addition agents AIDS amplification analysis antibodies antigen antiviral appear assay associated blood cause cell culture cell lines Center chronic Clin clinical collected containing detection determined developed diagnosis dilution direct disease drug effects evaluation fluid gene genome genotype Health hepatitis herpes human hybridization identification immune important increase individuals infection influenza isolates laboratory levels major measles medium methods Microbiol molecular mutations negative occur patients performed plasma polymerase positive present primary primers probes procedures protein rabies rapid reaction reactive recent reference region replication reported resistance respiratory response rubella samples sensitivity sequence serologic serum specific specimens staining studies Table therapy tion tissue titers transmission transplant treatment United usually vaccine viral Virol virus virus infection viruses weeks Western blot